Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (11 quarters reported)
$775M in Q2 2022 → $947M now. Hover for any quarter.
As reported for the quarter ended September 30, 2026. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| WH Waystar Hldg Corp | 66.5% | Unchanged | 24,879,437 | $630M |
| Pharvaris N V | 11.5% | Unchanged | 3,424,609 | $109M |
| Oculis Holding Ag | 6.9% | Unchanged | 6,950,294 | $64.9M |
| Agomab Therapeutics Nv | 6.0% | Unchanged | 5,141,992 | $57.1M |
| Evommune Inc | 4.6% | Unchanged | 5,288,313 | $43.7M |
| ET Electra Therapeutics Inc | 4.5% | New | 3,795,281 | $42.7M |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended September 30, 2026 · filed November 12, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| ET Electra Therapeutics Inc | New | +3,795,281 | +$42.7M | 4.5% |
quarter ended June 30, 2026 · filed August 13, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Oculis Holding Ag | Added | +1,050,000 | +$14.6M | 11.2% |
| Evommune Inc | Added | +358,680 | +$4.77M | 8.1% |
quarter ended March 31, 2026 · filed May 14, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Agomab Therapeutics Nv | New | +5,141,992 | +$53.9M | 5.3% |
quarter ended December 31, 2025 · filed February 11, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| KG Kodiak Gas Svcs Inc | Exited | −19,762,573 | −$731M | — |
| Evommune Inc | New | +4,929,633 | +$84.4M | 7.6% |
quarter ended September 30, 2025 · filed November 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| WH Waystar Hldg Corp | New | +24,879,437 | +$943M | 50.6% |
| KG Kodiak Gas Svcs Inc | New | +19,762,573 | +$731M | 39.2% |
| Oculis Holding Ag | New | +5,900,294 | +$104M | 5.6% |
| Pharvaris N V | New | +3,424,609 | +$85.4M | 4.6% |
| N None | Exited | +0 | — | — |
quarter ended September 30, 2023 · filed October 30, 2023
No position changes this quarter.
quarter ended June 30, 2023 · filed August 09, 2023
No position changes this quarter.
quarter ended March 31, 2023 · filed April 19, 2023
No position changes this quarter.
Loading...